These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7990105)
81. [A new antihypertensive agent of the fused pseudothiourea series: naphtho [1,2-d]thiazolo [3,2-a]-2-imidazoline]. Liu KC; Shih CY; Tuan JY; Chen SF Arch Pharm (Weinheim); 1978 Mar; 311(3):267-9. PubMed ID: 655795 [No Abstract] [Full Text] [Related]
82. Design, Synthesis and Fungicidal Activity of 2-Substituted Phenyl-2-oxo-, 2-Hydroxy- and 2-Acyloxyethylsulfonamides. Wang M; Rui P; Liu C; Du Y; Qin P; Qi Z; Ji M; Li X; Cui Z Molecules; 2017 May; 22(5):. PubMed ID: 28471409 [TBL] [Abstract][Full Text] [Related]
83. Acylsulfonamide-Functionalized Zwitterionic Gold Nanoparticles for Enhanced Cellular Uptake at Tumor pH. Mizuhara T; Saha K; Moyano DF; Kim CS; Yan B; Kim YK; Rotello VM Angew Chem Int Ed Engl; 2015 May; 54(22):6567-70. PubMed ID: 25873209 [TBL] [Abstract][Full Text] [Related]
84. Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere. Downey JD; Saleh SA; Bridges TM; Morrison RD; Daniels JS; Lindsley CW; Breyer RM Bioorg Med Chem Lett; 2013 Jan; 23(1):37-41. PubMed ID: 23218714 [TBL] [Abstract][Full Text] [Related]
85. Carboxylic acid isosteres improve the activity of ring-fused 2-pyridones that inhibit pilus biogenesis in E. coli. Berg V; Das P; Chorell E; Hedenström M; Pinkner JS; Hultgren SJ; Almqvist F Bioorg Med Chem Lett; 2008 Jun; 18(12):3536-40. PubMed ID: 18499455 [TBL] [Abstract][Full Text] [Related]
86. In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors. Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Chang RS; Ondeyka DL; Mantlo NB; Gibson RE; Greenlee WJ; Siegl PK Eur J Pharmacol; 1995 Dec; 294(2-3):439-50. PubMed ID: 8750704 [TBL] [Abstract][Full Text] [Related]
87. In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996. Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Schorn TW; Schaffer LW; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ Am J Hypertens; 1995 Jan; 8(1):58-66. PubMed ID: 7734099 [TBL] [Abstract][Full Text] [Related]
88. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193 [TBL] [Abstract][Full Text] [Related]
89. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent. Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028 [TBL] [Abstract][Full Text] [Related]
90. Angiotensin II receptors and angiotensin II receptor antagonists. Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104 [No Abstract] [Full Text] [Related]